| Product NDC: | 51808-127 |
| Proprietary Name: | P32 Sodium Phosphate |
| Non Proprietary Name: | P32 Sodium Phosphate |
| Active Ingredient(s): | 5 mCi/mL & nbsp; P32 Sodium Phosphate |
| Administration Route(s): | INTERSTITIAL; INTRA-ARTICULAR; INTRAPERITONEAL; INTRAPLEURAL |
| Dosage Form(s): | INJECTION, SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 51808-127 |
| Labeler Name: | AnazaoHealth Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | |
| Marketing Category: | UNAPPROVED DRUG OTHER |
| Start Marketing Date: | 20120619 |
| Package NDC: | 51808-127-01 |
| Package Description: | 3 mL in 1 VIAL (51808-127-01) |
| NDC Code | 51808-127-01 |
| Proprietary Name | P32 Sodium Phosphate |
| Package Description | 3 mL in 1 VIAL (51808-127-01) |
| Product NDC | 51808-127 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | P32 Sodium Phosphate |
| Dosage Form Name | INJECTION, SUSPENSION |
| Route Name | INTERSTITIAL; INTRA-ARTICULAR; INTRAPERITONEAL; INTRAPLEURAL |
| Start Marketing Date | 20120619 |
| Marketing Category Name | UNAPPROVED DRUG OTHER |
| Labeler Name | AnazaoHealth Corporation |
| Substance Name | PHOSPHORUS P-32 |
| Strength Number | 5 |
| Strength Unit | mCi/mL |
| Pharmaceutical Classes |